Efient
NICE extends recommendation for Efient
July 24, 2014Sales and Marketing ACS, Efient, NICE, Plavix, longs ton, prasugrel
In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
Efient fails to prove superiority to Plavix
August 29, 2012Brillinta, Efient, Plavix, prasugrel, ticagrelor
Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …
Merck’s vorapaxar fails in late-stage trial
November 15, 2011ACS, Brilinta, Efient, Merck, Plavix, antiplatelet, vorapaxar
Merck’s novel blood thinner vorapaxar has failed to meet its primary endpoint in a late-stage study.The TRACER trial compared vorapaxar …
NICE backs limited use of Lilly’s Plavix rival
September 7, 2009Research and Development Efient, NICE
NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …
Companies try to quell rumours on prasugrel
October 17, 2008Sales and Marketing Efient, lilly
Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
